Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
07/2000
07/19/2000EP1019095A1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
07/19/2000EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
07/19/2000EP0679091B1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization
07/18/2000US6090925 Macromolecular microparticles and methods of production and use
07/18/2000US6090923 Immunoglobulin that preferentially binds a human cytotoxin; for the treatment of virus infected or tumor target cells
07/18/2000US6090920 Aminoterminal propeptides of typed 1 procollagen
07/18/2000US6090913 Transesterification and other conversion reactions of acid derivatives, using an amidine base
07/18/2000US6090912 Multiplicity of separate solid supports with surface having suceptible linker to single species of test compound and with interior having attached non-cleavable coding molecule; for screening ligands or acceptors
07/18/2000US6090789 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof
07/18/2000US6090292 Device for purifying solutions containing proteins and use of the device
07/18/2000US6090288 Using an anion exchanger having ligands containing a primary, secondary or tertiary amino group covalently bound to the matrix, e.g. agarose, and 2 or 3 carbons from the matrix are an hydroxyl group or amine; high elution ionic strength
07/18/2000CA2087087C Molecules for iontophoretic delivery
07/18/2000CA2017315C Interleukin i inhibitor
07/18/2000CA2011031C Plasmodium merozoite rhoptries antigen and derivatives thereof
07/18/2000CA1341053C Polypeptide and protein derivatives and process for their preparation
07/13/2000WO2000040602A1 Binding molecules for human factor viii and factor viii-like proteins
07/13/2000WO2000040598A1 Separation method utilizing liquid-liquid partition
07/13/2000WO2000018351A3 Aglyco products and methods of use
07/13/2000WO2000015653A3 Apparatus for, and method of, storing a plurality of chemical compounds
07/13/2000DE19847074C1 Verfahren zum Entfernen von Lipopolysacchariden aus wäßrigen, proteinhaltigen Lösungen A method for removing lipopolysaccharides from aqueous, protein-containing solutions
07/13/2000CA2356704A1 Separation method utilizing liquid-liquid partition
07/13/2000CA2354599A1 Binding molecules for human factor viii and factor viii-like proteins
07/12/2000EP1018516A1 Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline
07/12/2000EP1018365A2 Coded particles for process sequence tracking in combinatorial compound library preparation
07/12/2000EP1017711A2 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action
07/12/2000EP1017286A1 Sequential separation of whey proteins and formulations thereof
07/12/2000EP0580694B1 Production of phosphopeptides from casein
07/12/2000CN2387106Y Growth liquid/liquid diffusion crystallization chamber for protein crystal
07/12/2000CN1259523A Immuno active polypeptide for treating psoriasis and its prepn. method
07/11/2000US6087335 Administering a polypeptide isolated from coriolus versicolor as an antitumor agent
07/11/2000US6087325 Peptide-lipid conjugates
07/11/2000US6087186 Synthetic library of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer; for drug screening
07/11/2000US6087161 Recombinant polynucleotide of promoter and sequence encoding protein with translation stop codon in open reading frame at 3' end resuling in deletion of c-terminal amino acids important for vacuolar targeting; for fungi resistant plants
07/11/2000US6087148 Method of purification of cellulose from a broth solution by crystallization
07/11/2000US6086849 Reagent for preparing a scintigraphic imaging agent, comprising a specific binding peptide having a radiolabel binding moiety that forms a neutral complex when bound to a radioisotope
07/11/2000CA1341048C Method and compositions for making acsf and acsf antagonists
07/06/2000WO2000039165A1 Serine protease inhibitor
07/06/2000WO2000038743A1 Removal of biological contaminants
07/06/2000WO2000038651A1 BIODEGRADABLE pH/THERMOSENSITIVE HYDROGELS FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS
07/06/2000WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS
07/06/2000WO1999054784A9 Free-form nanofabrication using multi-photon excitation
07/06/2000DE19858188A1 Apparatus for dissolving albumin flakes in a liquid contained in a bottle of circular cross-section.
07/06/2000CA2621097A1 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
07/06/2000CA2356894A1 Removal of biological contaminants
07/06/2000CA2356424A1 Serine protease inhibitor
07/05/2000EP1016716A2 Dna encoding a growth factor specific for epithelial cells
07/05/2000EP1015885A2 Purification of substances from a biological sample
07/05/2000EP1015878A1 Methods for fabricating enclosed microchannel structures
07/05/2000EP1015568A1 METHOD FOR THE PRODUCTION OF rDSPA Alpha1
07/05/2000EP1015479A1 Combinatorial libraries of peptidomimetic macrocycles and processes therefor
07/05/2000EP1015013A1 TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY beta-AMYLOID PEPTIDES
07/05/2000EP1015009A1 Attenuated vif dna immunization cassettes for genetic vaccines
07/05/2000EP0577752B1 Human pf4a receptors and their use
07/05/2000CN1259140A Treatment of insulin resistance with growth hormone secretagogues
07/05/2000CN1054159C Separation of proteins
07/04/2000US6084066 Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
07/04/2000US6084062 Polypeptides that bind to tissue plasminogen activator (tPA)
07/04/2000US6083917 Farnesyltransferase inhibitor peptide having specified tetrapeptide sequence
07/04/2000US6083910 Therapeutic uses of resolved intact or clipped native-sequence PDGF-BB dimers
07/04/2000US6083723 Vector comprising regulatory nucleotide sequences and nucleic acids that code for a exogenous polypeptide
07/04/2000US6083697 Chemical amplification for the synthesis of patterned arrays
07/04/2000CA2082799C Process for preparing peptides
06/2000
06/29/2000WO2000037484A1 Process for the preparation of amino acid amides or derivatives thereof
06/29/2000WO2000037156A1 Continuous method for separating substances according to molecular size
06/29/2000WO2000012542A3 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
06/29/2000WO2000012506A3 Collections of compounds
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/28/2000EP1013662A1 Reaction products between carboxylic acid and amino acid or amino acid condensate and process for producing the same
06/28/2000EP1013285A2 Urokinase-type plasminogen activator receptor
06/28/2000EP1013284A2 Purified forms of dnase
06/28/2000EP1012191A1 Method for obtaining high-purity vwf or factor viii/vwf complex
06/28/2000EP1012178A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
06/28/2000EP1012165A1 Process for the preparation of n-methyl-d-phenylalanyl-n- 1- 3- (aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-l-prolinamide
06/28/2000EP1012163A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium
06/28/2000EP0915710B1 Stable radioiodine conjugates and methods for their synthesis
06/28/2000EP0811058B1 A process for the preparation of factor ix from biological sources
06/28/2000EP0557418B1 A beta-type transforming growth factor
06/28/2000CN1257870A Process for separating and purifying heat-shock protein-polypeptide compound as antigen of tumor
06/28/2000CN1053964C Immunochemical detection of in vivo advanced glycosylation endproducts
06/28/2000CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition
06/27/2000US6081766 Machine-learning approach to modeling biological activity for molecular design and to modeling other characteristics
06/27/2000US6080844 Process for the recovery and purification of a recombinant protein from a cell
06/22/2000WO2000036398A2 Method and devices for detecting optical properties, especially luminescence reactions and refraction behaviour of molecules which are directly or indirectly bound on a support
06/22/2000WO2000036136A1 Metallopeptide combinatorial libraries and applications
06/22/2000WO2000036133A1 Process for producing polypeptide in cell-free protein synthesis system
06/22/2000WO2000036093A2 Intein-mediated cyclization of peptides
06/22/2000WO2000035941A2 Combinatorial process for preparing polyamines
06/22/2000WO2000035940A2 Method and devices for applying substances to a support, especially monomers for the combinatorial synthesis of molecule libraries
06/22/2000WO2000035427A1 Methods for reducing the immunogenicity of proteins, tissues, or organs
06/22/2000CA2355934A1 Intein mediated cyclization of peptides
06/22/2000CA2355880A1 Process for preparing polyamines
06/22/2000CA2354534A1 Process for producing polypeptide in cell-free protein synthesis system
06/22/2000CA2353072A1 Metallopeptide combinatorial libraries and applications
06/21/2000EP1010681A1 Preparation method of physiologically active compound
06/21/2000EP1009757A1 Modular protein libraries and methods of preparation
06/21/2000EP1009726A1 Fluorination of proteins and peptides for f-18 positron emission tomography
06/21/2000EP0205564B2 Method for the production of erythropoietin
06/21/2000DE19940750A1 Substrate for analysis includes microchannels with predetermined pattern of receptors deposited and immobilized under computer control by light- or liquid-induced polymerization
06/21/2000DE19858892A1 Continuous chromatographic separation of matter by molecular sizes useful e.g. for separation of isomers, uses a simulated moving bed for size exclusion chromatography